Application 205749
- Type
- ANDA
- Sponsor
- GLAND PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZOLEDRONIC | ZOLEDRONIC ACID | INJECTABLE;INTRAVENOUS | EQ 4MG BASE/100ML | No | No |
| 002 | ZOLEDRONIC ACID | ZOLEDRONIC ACID | INJECTABLE;IV (INFUSION) | EQ 4MG BASE/100ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68083-142 | Zoledronic Acid | zoledronic Acid | Gland Pharma Limited | ANDA | Current |
| 68083-142 | Zoledronic Acid | zoledronic Acid | Gland Pharma Limited | ANDA | Current |
| 70860-210 | Zoledronic Acid | zoledronic acid | Athenex Pharmaceutical Division, LLC. | ANDA | Current |
| 70860-210 | Zoledronic Acid | zoledronic acid | Athenex Pharmaceutical Division, LLC. | ANDA | Current |